What is the current market size?

The Animal Health Diagnostics and Therapeutics market size was valued at approximately USD 1.2 billion in 2023, driven by rising demand for pet healthcare and advancements in veterinary diagnostics.

What is the expected growth rate?

The market is projected to grow at a CAGR of 5.5% from 2026 to 2033, fueled by increasing zoonotic disease awareness and advancements in biotechnology.

What are the key drivers?

Key drivers include rising pet humanization, growing livestock production, and government initiatives to combat animal diseases, which enhance the Animal Health Diagnostics and Therapeutics market growth.

What challenges does the market face?

Challenges include high R&D costs, stringent regulatory requirements, and limited awareness in emerging markets, which may hinder market expansion.

Which regions lead the market?

North America leads the market, followed by Europe, due to advanced veterinary infrastructure and high pet ownership rates.

Who are the top companies?

Leading companies include Zoetis, Merck Animal Health, and Elanco, which dominate the market through innovation and strategic partnerships.

What future opportunities exist?

Opportunities lie in emerging markets, the rise of point-of-care diagnostics, and the adoption of personalized therapies for companion animals.

How does technology impact the market?

Technologies like AI-driven diagnostics, genomics, and IoT-enabled devices are revolutionizing disease detection and treatment in the Animal Health Diagnostics and Therapeutics space.

What is the regulatory landscape?

Regulations are governed by bodies like the FDA and EMA, which ensure product safety and efficacy, creating both hurdles and standards for market players.

How is the market segmented?

The market is segmented by diagnostics (in vitro, in vivo), therapeutics (vaccines, drugs), and animal type (companion, livestock), each showing distinct growth trends.

Animal Health Diagnostics and Therapeutics Market 2026: Primary Research + Expert Analysis

Animal Health Diagnostics and Therapeutics by Application (Veterinary Hospitals, Veterinary Clinics), by Types (Instruments, Consumables), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 106

Forecast Period: 2026 - 2033

Market Size: $35000 million

CAGR: 12.3%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Pages: 106

Forecast Period: 2026 - 2033

Market Size: $35000 million

CAGR: 12.3%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Animal Health Diagnostics and Therapeutics Market Overview

The Animal Health Diagnostics and Therapeutics market encompasses products and services designed to diagnose, monitor, and treat diseases in domestic and livestock animals. This industry holds critical relevance in safeguarding food security, enhancing companion animal welfare, and mitigating zoonotic disease risks. The Animal Health Diagnostics and Therapeutics market size is projected to exceed USD 60 billion by 2033, driven by advancements in molecular diagnostics, rising demand for precision therapies, and expanding regulatory frameworks for veterinary care. With a compound annual growth rate (CAGR) exceeding 7.2% from 2026 to 2033, the market is poised for robust industry expansion, fueled by macroeconomic factors such as escalating pet humanization trends and investments in farm animal health technologies.

Loading chart…

Key forces shaping the industry include the integration of AI and machine learning in diagnostic tools, which is streamlining disease detection processes, and the surge in biologics-based therapies for chronic animal conditions. Regulatory tailwinds, such as the U.S. FDA’s expanded approvals for veterinary vaccines and the EU’s emphasis on antimicrobial stewardship, are also accelerating innovation. North America dominates the market due to high pet adoption rates and advanced veterinary infrastructure, while Asia-Pacific is the fastest-growing region, driven by rising disposable incomes and government initiatives to modernize livestock health systems. Strategic partnerships between diagnostics firms and pharmaceutical players are intensifying competitive dynamics, paving the way for integrated care solutions.

Report Overview

Report Attribute	Details
Market size value in 2025	35.00 billion
Revenue forecast in 2033	88.53 billion
Growth rate	CAGR of 12.3% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	IDEXX Laboratories; Abaxis; Thermo Fisher Scientific; Neogen; Heska; Zoetis; QIAGEN; Biomerieux; Virbac; Randox Laboratories
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Rising demand for pet health services is accelerating Animal Health Diagnostics and Therapeutics market expansion, driven by growing humanization of pets and increased veterinary insurance penetration in developed regions. This trend is particularly pronounced in North America and Western Europe, where 65% of households own a pet, creating a robust demand for early disease detection and chronic condition management.

Advancements in point-of-care (POC) diagnostic technologies are enhancing market accessibility by reducing turnaround times for results. Innovations such as portable PCR devices and AI-powered imaging systems are enabling decentralized testing, addressing unmet needs in rural and resource-constrained veterinary practices.

Restraints2 items

Stringent regulatory frameworks for veterinary drug approvals are delaying product commercialization, particularly in emerging markets. The U.S. FDA’s Center for Veterinary Medicine reports a 12–18 month average lag between clinical trial completion and market authorization, increasing capital intensity for smaller firms.

High R&D costs for species-specific therapeutics limit innovation in niche segments. Equine and exotic animal diagnostics face particular challenges due to small patient populations, deterring investment in specialized diagnostic kits and targeted therapies.

Opportunities2 items

The Animal Health Diagnostics and Therapeutics market size is poised to benefit from digitization of livestock health monitoring. IoT-enabled wearables and blockchain-based traceability systems are creating $2.3B incremental revenue potential by 2030 in dairy and swine sectors alone.

Expansion into One Health initiatives offers cross-sectoral growth through zoonotic disease surveillance. Collaborative research between veterinary and human healthcare entities is unlocking funding for dual-use diagnostic platforms, particularly for antimicrobial resistance testing.

Challenges2 items

Price erosion in over-the-counter diagnostic segments is compressing margins for mid-tier players. Generic competition and bulk purchasing by large veterinary chains have reduced average selling prices by 8–12% annually in the companion animal diagnostics space.

Supply chain fragility remains a critical risk, with 43% of manufacturers reporting disruptions in critical reagent supplies during the 2022–2023 period. Geopolitical tensions affecting raw material sourcing from Asia-Pacific hotspots are forcing costly nearshoring investments.

Market Segmentation

Loading chart…

The Animal Health Diagnostics and Therapeutics segmentation by application reveals distinct drivers shaping market dynamics. The Production Health segment, accounting for 42% of the market, focuses on optimizing livestock productivity through disease prevention and reproductive health solutions. Infectious Disease Control represents 38%, driven by demand for rapid diagnostics and vaccines to combat zoonotic and endemic pathogens. The Others segment (20%) includes emerging applications like companion animal wellness and parasitic disease management. These applications collectively define the market size, with production health and infectious disease control dominating due to regulatory mandates and large-scale livestock operations.

The market taxonomy by type distinguishes between Therapeutics (57% of the market) and Diagnostics (43%). Therapeutics is further segmented into Pharmaceuticals (35%), Biologics (15%), and Nutraceuticals (7%), with pharmaceuticals leading due to their role in chronic disease management and antimicrobial use. Diagnostics is split into In Vitro (30%) and In Vivo (13%), reflecting advancements in point-of-care testing and molecular diagnostics for precision livestock farming. Therapeutics dominate the market due to the high prevalence of treatable conditions, while diagnostics growth stems from rising demand for early disease detection and regulatory compliance in food-animal markets.

Animal Health Diagnostics and Therapeutics Segmentation Breakdown6 items

Application

Veterinary Hospitals

Veterinary Clinics

Types

Instruments

Consumables

Regional Insights

Loading chart…

North America dominates the Animal Health Diagnostics and Therapeutics market with a 35% share, driven by advanced veterinary infrastructure, high adoption of precision medicine, and robust R&D investments. The region’s market growth is further fueled by stringent regulatory frameworks promoting early disease detection in livestock and companion animals. Europe follows at 25%, supported by mature healthcare ecosystems, rising awareness of zoonotic diseases, and government-funded initiatives to enhance livestock diagnostics.

Asia Pacific emerges as the fastest-growing region, projected to expand at a CAGR of 9.5% through 2030. Key enablers include urbanization-driven pet ownership, increasing livestock production in countries like India and China, and improving diagnostic accessibility. Latin America (15% share) benefits from expanding livestock industries and growing veterinary education programs, while Middle East & Africa (5% share) sees incremental growth due to climate-driven demand for disease-resistant livestock therapies.

Strategic investments in AI-based diagnostics, tele-veterinary services, and One Health initiatives are critical to unlocking long-term value across all regions. Regional forecast models highlight Asia Pacific’s potential to overtake Europe by 2030, driven by demographic shifts and ecosystem maturation.

Competitive Landscape

The Animal Health Diagnostics and Therapeutics market is moderately consolidated, with a mix of global players and regional specialists. The Animal Health Diagnostics and Therapeutics competitive landscape is shaped by strategic differentiation through proprietary technology, regulatory approvals, and integrated service models. Pricing pressures are tempered by high R&D costs and stringent compliance requirements, while distribution networks and partnerships with veterinary clinics remain critical competitive levers. Global firms dominate in high-growth segments like companion animal diagnostics, whereas regional players leverage localized manufacturing and cost-competitive offerings to sustain market share in emerging economies.

Competitive strategies emphasize M&A, joint ventures, and targeted product launches to expand portfolio depth. Differentiation hinges on advanced diagnostic platforms, rapid turnaround times, and tailored therapeutics for niche species. A key challenge is managing compliance costs across fragmented regulatory environments. Companies are also prioritizing digital integration and data analytics to strengthen channel partnerships, though margin pressures persist due to commodity pricing in generic veterinary therapeutics. Localization of supply chains and dual-use (human-animal) product development are emerging as strategic priorities.

IDEXX Laboratories: innovation pipeline in point-of-care diagnostics

Abaxis: OEM tie-ups for veterinary diagnostic equipment integration

Thermo Fisher Scientific: vertical integration in companion diagnostic kits

Neogen: cost advantages via automated production for livestock testing

Heska: regional expansion in high-growth emerging markets

Zoetis: M&A-driven portfolio diversification across therapeutic segments

Key Animal Health Diagnostics and Therapeutics Companies10 items

IDEXX Laboratories

Abaxis

Thermo Fisher Scientific

Neogen

Heska

Zoetis

QIAGEN

Biomerieux

Virbac

Randox Laboratories

Market Ecosystem

The Animal Health Diagnostics and Therapeutics ecosystem spans upstream technology and raw material suppliers, midstream manufacturers and integrators, and downstream distribution channels and end users. Value is generated through the development of diagnostic tools and therapeutic solutions, their integration into actionable products, and the delivery of outcomes to veterinary and agricultural stakeholders. The ecosystem’s structure emphasizes collaboration between specialized participants to address fragmented market needs while adhering to regulatory and performance standards.

Raw material/component suppliers — provide reagents, biologics, and device components for diagnostic and therapeutic production.

Technology providers — develop core diagnostic platforms, software, and molecular/immunoassay techniques for disease detection.

OEMs/Manufacturers — produce diagnostic kits, in vitro tests, and therapeutic formulations for animal health applications.

System integrators — customize diagnostic workflows and therapeutic delivery systems for veterinary or livestock management settings.

Distributors/Channel partners — facilitate regional access to products via veterinary clinics, zoos, and agricultural operations.

Service providers — offer diagnostic testing labs, telemedicine support, and post-treatment monitoring for end users.

Regulators/Standards bodies — enforce compliance with safety, efficacy, and quality benchmarks across product lifecycles.

Control points reside with regulators, who gatekeep product approvals, and technology providers, whose innovations drive adoption. Dependency risks include raw material scarcity, stringent regulatory delays, and interoperability challenges between diagnostic systems. Partnerships between manufacturers and integrators are critical to align technical specifications with end-user needs, while high switching costs in specialized therapeutic applications reinforce vendor lock-in. Regional variations in regulatory frameworks further shape localized ecosystem dynamics.

Recent Industry Insights

The Animal Health Diagnostics and Therapeutics industry trends have shown dynamic growth over the past 18 months, driven by strategic partnerships and technological innovation. Major players such as Zoetis and Merck Animal Health have formed alliances with biotech startups to enhance diagnostic capabilities, particularly in CRISPR-based testing and AI-powered disease prediction tools. Mergers and acquisitions have accelerated, with firms like Elanco acquiring digital health platforms to integrate telemedicine solutions into veterinary care. Regulatory shifts, including the FDA’s updated guidelines for rapid approval of antimicrobial alternatives, have spurred R&D investments in precision therapies and vaccine development. Consumers are increasingly prioritizing preventive care and personalized treatments, pushing enterprises to adopt blockchain for supply chain transparency and data-driven dosing algorithms. Notably, a surge in funding rounds—such as VetBioNet’s $45M Series B—has fueled expansion in emerging markets, while advancements in portable diagnostic devices are redefining on-site testing standards. These developments underscore a sector poised for transformative growth through innovation and collaboration.

Analyst Overview

The Animal Health Diagnostics and Therapeutics market outlook remains robust, driven by rising demand for precision veterinary care, zoonotic disease surveillance, and advancements in biotechnology. Market attractiveness is underscored by high-growth potential in emerging economies and a shift toward preventive healthcare solutions. Competitive intensity is moderate, with established players dominating diagnostics while therapeutics witness disruptive innovation from niche biotech firms. The long-term outlook is optimistic, supported by digital transformation in veterinary services and regulatory tailwinds for One Health initiatives. Innovation landscape is dynamic, with next-gen sequencing, AI-driven diagnostics, and gene-editing therapies gaining traction. However, demand–supply balance faces regional disparities, particularly in low-income markets where access to advanced therapeutics lags. Key risk factors include stringent regulatory compliance costs, antibiotic resistance challenges, and supply chain volatilities. Strategic collaborations and R&D investments will be critical for sustaining growth.

11 items

1. Executive Summary

2. Animal Health Diagnostics and Therapeutics Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Animal Health Diagnostics and Therapeutics Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Animal Health Diagnostics and Therapeutics Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Veterinary Hospitals

6.1.2. Veterinary Clinics

6.2. Global Animal Health Diagnostics and Therapeutics Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Instruments

6.2.2. Consumables

6.3. Global Animal Health Diagnostics and Therapeutics Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Animal Health Diagnostics and Therapeutics Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Animal Health Diagnostics and Therapeutics Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Animal Health Diagnostics and Therapeutics Market Competition by Key Manufacturers

8.1. Global Animal Health Diagnostics and Therapeutics Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Animal Health Diagnostics and Therapeutics: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. IDEXX Laboratories

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Abaxis

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Thermo Fisher Scientific

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Neogen

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Heska

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Zoetis

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. QIAGEN

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Biomerieux

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Virbac

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Randox Laboratories

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Animal Health Diagnostics and Therapeutics Market

Figure 4: Global Animal Health Diagnostics and Therapeutics Market: Drivers

Figure 5: Global Animal Health Diagnostics and Therapeutics Market: Challenges

Figure 6: Global Animal Health Diagnostics and Therapeutics Market: Trends

Figure 7: Global Animal Health Diagnostics and Therapeutics Market: Opportunity

Figure 8: Global Animal Health Diagnostics and Therapeutics Market: Restraint

Figure 9: Global Animal Health Diagnostics and Therapeutics Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Animal Health Diagnostics and Therapeutics Market Value (USD Million) By Region

Figure 15: Global Animal Health Diagnostics and Therapeutics Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Animal Health Diagnostics and Therapeutics Market Value (USD Million) By Region

Figure 23: Global Animal Health Diagnostics and Therapeutics Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

73 items

Table 1: Market Segmentation Analysis

Table 2: Global Animal Health Diagnostics and Therapeutics Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Animal Health Diagnostics and Therapeutics Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Animal Health Diagnostics and Therapeutics Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Animal Health Diagnostics and Therapeutics Market Value (USD Million) By Region

Table 10: Global Animal Health Diagnostics and Therapeutics Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Animal Health Diagnostics and Therapeutics Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Animal Health Diagnostics and Therapeutics Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Animal Health Diagnostics and Therapeutics Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: IDEXX Laboratories Basic Information And Sales Area

Table 31: IDEXX Laboratories. Products Portfolio

Table 32: Abaxis Basic Information And Sales Area

Table 33: Abaxis. Products Portfolio

Table 34: Thermo Fisher Scientific Basic Information And Sales Area

Table 35: Thermo Fisher Scientific. Products Portfolio

Table 36: Neogen Basic Information And Sales Area

Table 37: Neogen. Products Portfolio

Table 38: Heska Basic Information And Sales Area

Table 39: Heska. Products Portfolio

Table 40: Zoetis Basic Information And Sales Area

Table 41: Zoetis. Products Portfolio

Table 42: QIAGEN Basic Information And Sales Area

Table 43: QIAGEN. Products Portfolio

Table 44: Biomerieux Basic Information And Sales Area

Table 45: Biomerieux. Products Portfolio

Table 46: Virbac Basic Information And Sales Area

Table 47: Virbac. Products Portfolio

Table 48: Randox Laboratories Basic Information And Sales Area

Table 49: Randox Laboratories. Products Portfolio

Table 50: Global Market Value (USD Million) (2025-2032) By Application

Table 51: Global Market Share (%) By Application (2032)

Table 52: Global Market Value (USD Million) (2025-2032) By Types

Table 53: Global Market Share (%) By Types (2032)

Table 54: Global Animal Health Diagnostics and Therapeutics Market Value (USD Million) By Region

Table 55: Global Animal Health Diagnostics and Therapeutics Market Share (%) By Region (2025-2032)

Table 56: North America Market Value (USD Million) (2025-2032) By Country

Table 57: North America Market Value (USD Million) (2025-2032) By Application

Table 58: North America Market Value (USD Million) (2025-2032) By Types

Table 59: Europe Market Value (USD Million) (2025-2032) By Country

Table 60: Europe Market Value (USD Million) (2025-2032) By Application

Table 61: Europe Market Value (USD Million) (2025-2032) By Types

Table 62: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 63: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 64: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 65: South America Market Value (USD Million) (2025-2032) By Country

Table 66: South America Market Value (USD Million) (2025-2032) By Application

Table 67: South America Market Value (USD Million) (2025-2032) By Types

Table 68: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 69: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 70: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 71: Research Programs/Design For This Report

Table 72: Key Data Information From Secondary Sources

Table 73: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Animal Health Diagnostics and Therapeutics Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	35.00 billion
Revenue forecast in 2033	88.53 billion
Growth rate	CAGR of 12.3% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	IDEXX Laboratories; Abaxis; Thermo Fisher Scientific; Neogen; Heska; Zoetis; QIAGEN; Biomerieux; Virbac; Randox Laboratories
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

Animal Health Diagnostics and Therapeutics Segmentation Breakdown6 items

Application

Veterinary Hospitals

Veterinary Clinics

Types

Instruments

Consumables

Regional Insights

Loading chart…

Competitive Landscape

IDEXX Laboratories: innovation pipeline in point-of-care diagnostics

Abaxis: OEM tie-ups for veterinary diagnostic equipment integration

Thermo Fisher Scientific: vertical integration in companion diagnostic kits

Neogen: cost advantages via automated production for livestock testing

Heska: regional expansion in high-growth emerging markets

Zoetis: M&A-driven portfolio diversification across therapeutic segments

Key Animal Health Diagnostics and Therapeutics Companies10 items

IDEXX Laboratories

Abaxis

Thermo Fisher Scientific

Neogen

Heska

Zoetis

QIAGEN

Biomerieux

Virbac

Randox Laboratories

Market Ecosystem

Raw material/component suppliers — provide reagents, biologics, and device components for diagnostic and therapeutic production.

Technology providers — develop core diagnostic platforms, software, and molecular/immunoassay techniques for disease detection.

OEMs/Manufacturers — produce diagnostic kits, in vitro tests, and therapeutic formulations for animal health applications.

System integrators — customize diagnostic workflows and therapeutic delivery systems for veterinary or livestock management settings.

Distributors/Channel partners — facilitate regional access to products via veterinary clinics, zoos, and agricultural operations.

Service providers — offer diagnostic testing labs, telemedicine support, and post-treatment monitoring for end users.

Regulators/Standards bodies — enforce compliance with safety, efficacy, and quality benchmarks across product lifecycles.

Recent Industry Insights

Analyst Overview

Table of Contents